Pre-Print Publication

Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38

View

Peer-Reviewed Publication

Absolute concentration estimation of COVID- 19 convalescent and post-vaccination IgG antibodies

View

Peer-Reviewed Publication

A next-generation Fab library platform directly yielding drug-like antibodies with high affinity, diversity, and developability

View

Peer-Reviewed Publication

Direct selection of functional fluorescent-protein antibody fusions by yeast display

View

Peer-Reviewed Publication

TitrationAnalysis: a tool for high throughput binding kinetics data analysis for multiple label-free platforms

View

Peer-Reviewed Publication

Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants

View

Peer-Reviewed Publication

Antibodies: Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBDoftheSARS-CoV-2 Spike Protein

View

Pre-Print Publication

Unlocking de novo antibody design with generative artificial intelligence

View

Pre-Print Publication

Analysis of the Diverse Antigenic Landscape of the Malaria Invasion Protein RH5 Identifies a Potent Vaccine-Induced Human Public Antibody Clonotype

View

Pre-Print Publication

Improving antibody affinity using laboratory data with language model guided design

View

Peer-Reviewed Publication

Widespread monoclonal IgE antibody convergence to an immunodominant, proanaphylactic Ara h 2 epitope in peanut allergy

View

Peer-Reviewed Publication

Science: LY-CoV555, a Rapidly Isolated Potent Neutralizing Antibody, Provides Protection in a Non-Human Primate Model of SARS-CoV-2 Infection

View

Peer-Reviewed Publication

Absci achieves a breakthrough in AI drug creation

View

Peer-Reviewed Publication

Healthy humans can be a source of antibodies countering COVID-19

View